Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease.
Carcinoid heart desease
Transcatheter pulmonary valve implantation
Journal
Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
28
10
2021
revised:
10
12
2021
accepted:
23
12
2021
pubmed:
17
1
2022
medline:
16
8
2022
entrez:
16
1
2022
Statut:
ppublish
Résumé
Carcinoid heart disease is a rare condition affecting mostly tricuspid and pulmonary valves causing right-sided heart failure. Surgical valve replacement is the mainstay of treatment when patients become symptomatic and/or in the presence of right heart remodeling. We present a case of severe pulmonary valve regurgitation secondary to carcinoid heart disease occurring 4 years after a surgical tricuspid replacement, successfully treated with direct transcatheter pulmonary valve implantation without pre-stenting.
Identifiants
pubmed: 35033459
pii: S1553-8389(21)00828-9
doi: 10.1016/j.carrev.2021.12.027
pii:
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
130-134Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest None.